Stanozolol

Stanozolol has been used with some success to treat venous insufficiency. It stimulates blood fibrinolysis and has been evaluated for the treatment of the more advanced skin changes in venous disease such as lipodermatosclerosis. Several randomized trials noted improvement in the area of lipodermatosclerosis, reduced skin thickness, and possibly faster ulcer healing rates with stanozolol.[13][14] It is also being studied to treat hereditary angioedema, osteoporosis, and skeletal muscle injury. stanozolol is not esterified and is sold as an aqueous suspension, or in oral tablet form.[7] The drug has a high oral bioavailability, due to a C17α alkylation which allows the hormone to survive first-pass liver metabolism when ingested.[9][7] It is because of this that stanozolol is also sold in tablet form.
Stanozolol is one of the AAS commonly used as performance-enhancing drugs and is banned from use in sports competition under the auspices of the International Association of Athletics Federations (IAAF) and many other sporting bodies. Additionally, stanozolol has been highly restricted in US horse racing.[